ABSTRACT In this study, we report the first draft genome sequence of Microbacterium esteraromaticum MM1, isolated from golf course soil in South Australia. The genome possesses genes for the hydrolysis of organophosphorus (OP) pesticides and polycyclic aromatic hydrocarbon (PAH) degradation.
500 bp and were removed from the analysis. Annotations of contigs were carried out using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (https://www.ncbi .nlm.nih.gov/genomes/static/Pipeline.html), which identified 3,363 genes, 3,277 coding sequences, 229 pseudogenes, 8 rRNA operons (4 complete and 4 partial), and 75 tRNA genes.
The genome also was found to contain gene clusters coding enzymes that might be involved in the metabolism of organophosphorus, organosulfur, and aromatic compounds such as phosphopyruvate hydratase (EC 4.2.1.11), salicylate hydroxylase (EC 1.14.13.1), catechol 1,2-dioxygenase (EC 1.13.11.1), shikimate 5-dehydrogenase (EC 1.1.1.25), monoamine oxidase (EC 1.4.3.4), and gentisate 1,2-dioxygenase (EC 1.13.11.4). Whole-genome sequences from the genus Microbacterium were previously reported in M. testaceum StLB037 (10), M. testaceum KU313 (11), M. laevaniformans OR221 (12), M. yannicii (13) , and M. nematophilum (14) . However, this is the first report of a draft genome of the genus Microbacterium with the ability to degrade OP pesticides and PAHs. The genome of strain MM1 facilitates an understanding of its biodegradation potential and also of its usefulness in the field of environmental remediation.
Data availability. The draft genome sequence of Microbacterium esteraromaticum MM1 generated in this study has been deposited at DDBJ/ENA/GenBank under the accession number PDVO00000000. The version described in this paper is version PDVO02000000.
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